Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. - Wikidata - awgldk - TriplyDB

Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice.

Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice.

http://www.wikidata.org/entity/Q40909568

about

Active and passive immunotherapy for neurodegenerative disorders Imaging of Leukocyte Trafficking in Alzheimer's Disease Development of positron emission tomography β-amyloid plaque imaging agents The dendritic hypothesis for Alzheimer's disease pathophysiology.Spines, plasticity, and cognition in Alzheimer's model mice Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.Advances in light microscopy for neuroscience.Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy Alzheimer disease models and human neuropathology: similarities and differences Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain.Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.Brain imaging of nicotinic receptors in Alzheimer's disease.Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis.Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity Passive (amyloid-β) immunotherapy attenuates monoaminergic axonal degeneration in the AβPPswe/PS1dE9 mice.Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy.Two-photon microscopy for chemical neuroscience.Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis.Impairments in experience-dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease.A Peephole into the Brain: Neuropathological Features of Alzheimer's Disease Revealed by in vivo Two-Photon Imaging Constitutive modeling of mouse carotid arteries using experimentally measured microstructural parameters.Diosgenin is an exogenous activator of 1,25D₃-MARRS/Pdia3/ERp57 and improves Alzheimer's disease pathologies in 5XFAD mice Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression.Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease.Two-photon imaging of synaptic plasticity and pathology in the living mouse brain.Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation.Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease.

P2860

Q24657879-C11AF9B7-86C3-40E2-8B5E-E3B34E8FFD4B Q26766489-75B1E6C0-9D21-4D70-8674-30FAF756D29A Q27012742-F807F916-EF6B-42D7-8E85-5A4B92304C71 Q27687404-F1C2FB3D-C6A4-4BDF-9379-D7E14A88D1C9 Q27691328-484F7441-7647-42F4-ABAD-FDB2DB8FB9F9 Q30479560-4862A9FD-1AE8-47AF-988A-8C51700A9919 Q30483377-8743726C-18E1-4965-8EB4-71E371BFB3EF Q30499456-8DAEF3DF-6F8D-4A33-968F-5F7A5F79F4B5 Q30499574-2D14B1EB-5A73-444D-8E90-6C60E1DE10DB Q30623665-38E74A0A-BA81-47C9-9AB5-7EA4CD868599 Q31087458-CE02DFCA-4D38-4128-9E79-47387D7C985B Q33616714-4FB82BB3-E5DA-4932-AA74-65034BEDE520 Q33740340-2DFE6C30-4411-4E17-96C9-DE5D10C8879C Q33808402-E5E1AE60-E179-4FB3-8EB6-A053559A65A7 Q34050850-380BE468-11A8-4435-B950-473BC7530CC0 Q34097562-C6877C96-FD5E-4C40-9117-724CE23C06F5 Q34107259-954BBFC4-9CF5-4CBA-AE63-8C611A3C791F Q34374743-A926CA7E-633F-49A3-9A0B-8BD67340EF95 Q34459388-D0405967-2598-4679-A7D6-AC0E1CFE422F Q34496928-DDACC543-25D1-4BDF-B17D-0D386F6FBD1C Q34554154-0B63A2B9-880A-4A31-9535-C99B6A990A1A Q34579152-7448A774-AE73-445E-A853-CBFCE12EBAD9 Q34701388-A9BA770F-E751-4CE2-8D55-FB7E5E644432 Q34717836-60B40DB2-5352-422C-ADE1-EFE610A9AE98 Q35015949-6B0128D4-502D-4C26-B516-B8BA945EB504 Q35075460-BDF40828-3765-4382-BF92-C1C4E7D7E331 Q35212180-123FD0BE-132C-4828-B61B-5ED1F6E8A767 Q35222043-EF688EB1-4FA3-4F20-A591-CBF92BA701A1 Q35684738-EA0E409A-4113-4E8C-ABAE-164B03AEE9A9 Q35864788-26999F2E-6F57-45C6-97AE-8015D51B9BE0 Q36045496-2CBFF8C0-339E-4075-A4B5-401A12EF8DA3 Q36117539-5C97E76D-E1B6-423F-8ACE-3E00CA868D2E Q36312553-E8CB6946-3210-4B09-B80E-4A9B8EC48540 Q36464551-E24ACF94-A675-454D-A985-6EF52C1542C0 Q36509219-E7FD723E-B44D-4E15-91A7-B7B3DABE39E2 Q36608820-9BDCD04A-D4D6-4183-8DD0-F84E21B4B374 Q36855702-656113D6-535A-4114-9765-1663E6EEE47D Q36968718-63BE06DC-7249-4DC1-89BC-829EACBE5075 Q37000563-A8F19BD9-EAE6-4A27-9007-3CDC380740F6 Q37015379-04A14CFF-7BE0-410B-BCFF-C4F656CD1100

P2860

Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice.

http://www.wikidata.org/entity/Q40909568

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Anti-Abeta antibody treatment ...... ophy in PDAPP transgenic mice.

@en

type

label

Anti-Abeta antibody treatment ...... ophy in PDAPP transgenic mice.

@en

prefLabel

Anti-Abeta antibody treatment ...... ophy in PDAPP transgenic mice.

@en

P1433

Q40909568-16FB760C-D1FC-4A84-9879-2D6EC810D62C

P1476

Q40909568-7E8897C4-E5FF-45B0-9AC5-E0CEE3664072

P2093

Q40909568-614AF178-2885-4788-9653-D9CE488EFA7B

Q40909568-6DD54350-4CA8-4F41-8D11-E44CBE1065C6

Q40909568-8F9378AB-3BA6-43CE-91C3-E211068064D0

Q40909568-9AFF3BCD-7BD6-4809-B3C6-95FC9F088874

Q40909568-A4081318-BC19-4E7B-9C65-0AEB2C3518C6

Q40909568-B7E99CCE-EF2B-4356-9723-A3CB12D55C83

Q40909568-C0FE7A90-7372-4481-AD19-8753636C9AC1

Q40909568-DB62F00B-F0C1-4CF4-98A6-0DA1A65B9212

Q40909568-F23710E0-2558-4B69-BB8F-9E017693B0DA

P2860

Q40909568-09F20689-CDAA-48A8-9535-DACB3840A3AE

Q40909568-15DBEE25-6D53-4505-B0EE-7243EC933DC4

Q40909568-1FFE8E22-8FE8-486A-8B82-20FE4F499024

Q40909568-231E5D22-5AD3-4557-8D1E-FAD6933ABB89

Q40909568-2429F7C5-985A-4DF6-953B-18AB6B54DF6A

Q40909568-3DD48703-436B-4844-B96F-6553D5EAE267

Q40909568-471E68DE-3A8E-4BCD-8C5B-0C8319FAF7C3

Q40909568-47F0F373-1958-4CEF-BE4E-E4B7BBBD5295

Q40909568-4C31ED9F-22FE-4C0F-9249-F3092D0628F1

Q40909568-4F6E627F-00BB-43CC-9604-081499ED3CCD

P304

Q40909568-8A7E7244-2000-430A-A628-8C84AB24D512

P31

Q40909568-B378FF8A-EEC7-4369-84D8-AC0D77A03202

P356

Q40909568-FB3E1378-DA2F-4E5D-B49C-A2DB6C7E6E3F

P407

Q40909568-4C83C60B-7641-45B6-B24C-2A65965C0B2A

P433

Q40909568-238640F4-41EC-4A4F-AECA-0391395C806C

P478

Q40909568-EEA4C414-7DFA-4D7A-A317-8293BD79E736

P50

Q40909568-1785E451-302E-436A-B371-FBBE639E9576

Q40909568-85D65D99-3838-45AD-A342-3D9B57529CD9

P577

Q40909568-0E23DD13-83F2-4934-8C71-3755D49B0B39

P698

Q40909568-4EC70A3A-6763-49AA-BCFD-CA50257628F2

P921

Q40909568-5B9E251B-AD98-4CFA-8D2E-253923021B87

P932

Q40909568-953F44D9-861E-4AF2-BA18-AA0449BEA6AB

P356

P1433

Journal of Clinical Investigation

P1476

Anti-Abeta antibody treatment ...... ophy in PDAPP transgenic mice.

@en

P2093

Brian J Bacskai

http://www.w3.org/2001/XMLSchema#string

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Jesse M Skoch

http://www.w3.org/2001/XMLSchema#string

John R Cirrito

http://www.w3.org/2001/XMLSchema#string

Kelly A Simmons

http://www.w3.org/2001/XMLSchema#string

Kelly R Bales

http://www.w3.org/2001/XMLSchema#string

Robert P Brendza

http://www.w3.org/2001/XMLSchema#string

Steven M Paul

http://www.w3.org/2001/XMLSchema#string

William E Klunk

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Alzheimer's disease: genes, proteins, and therapy

Reversible memory loss in a mouse transgenic model of Alzheimer's disease

Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy.

Imaging high-resolution structure of GFP-expressing neurons in neocortex in vivo.

Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy.

P304

428-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI23269

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

David M. Holtzman

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15668737

http://www.w3.org/2001/XMLSchema#string

P921

P932

544607

http://www.w3.org/2001/XMLSchema#string